Suven Life Sciences Ltd.

BSE: 530239 | NSE: SUVEN |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE495B01038 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Suven Life Sci Suven Life Sciences Ltd. | BSE 167.65 -1.70 (-1.00%) | NSE 168.10 -1.45 (-0.86%) | Trade | Add

BSE Live

Dec 11, 12:18

167.65 -1.70 (-1.00%)

Volume

AVERAGE VOLUME

5-Day

13,887

10-Day

15,493

30-Day

14,342

13,448

Prev. Close

169.35
Open Price

169.40

Bid Price (Qty.)
167.80 (328)
Offer Price (Qty.)
168.45 (144)

NSE Live

Dec 11, 12:18

168.10 -1.45 (-0.86%)

Volume

AVERAGE VOLUME

5-Day

192,670

10-Day

177,129

30-Day

151,551

306,098

Prev. Close

169.55
Open Price

169.55

Bid Price (Qty.)
168.10 (1)
Offer Price (Qty.)
168.26 (55)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Suven Life Sciences (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Per Share Ratios
Basic EPS (Rs.)	-7.37	-4.82	-6.63	-9.57	-5.67
Diluted EPS (Rs.)	-7.37	-4.82	-6.63	-9.57	-5.67
Cash EPS (Rs.)	-7.10	-4.52	-5.12	-8.09	-5.33
Book Value [ExclRevalReserve]/Share (Rs.)	5.04	12.38	17.21	6.61	8.49
Book Value [InclRevalReserve]/Share (Rs.)	5.04	12.38	17.21	6.61	8.49
Revenue from Operations/Share (Rs.)	0.31	0.54	0.62	0.81	1.06
PBDIT/Share (Rs.)	-7.10	-4.90	-5.39	-8.05	-5.68
PBIT/Share (Rs.)	-7.37	-5.20	-5.69	-8.35	-6.02
PBT/Share (Rs.)	-7.37	-4.86	-5.42	-8.39	-6.09
Net Profit/Share (Rs.)	-7.37	-4.82	-5.42	-8.39	-5.67
NP After MI And SOA / Share (Rs.)	-7.37	-4.82	-5.42	-8.39	-5.67
Profitability Ratios
PBDIT Margin (%)	-2,326.94	-914.01	-867.37	-988.42	-536.50
PBIT Margin (%)	-2,414.41	-969.62	-915.70	-1,025.51	-568.75
PBT Margin (%)	-2,415.11	-907.20	-873.52	-1,029.98	-574.80
Net Profit Margin (%)	-2,415.11	-898.63	-873.52	-1,029.98	-535.31
NP After MI And SOA Margin (%)	-2,415.11	-898.63	-873.52	-1,029.98	-535.31
Return on Networth/Equity (%)	-146.14	-38.91	-31.51	-126.88	-66.80
Return on Capital Employed (%)	-143.86	-41.77	-32.81	-121.80	-68.13
Return on Assets (%)	-118.90	-36.88	-30.41	-112.92	-56.18
Total Debt/Equity (X)	0.00	0.00	0.00	0.01	0.00
Asset Turnover Ratio (%)	0.03	0.03	0.03	0.04	10.49
Liquidity Ratios
Current Ratio (X)	3.21	18.99	22.61	8.01	6.45
Quick Ratio (X)	3.20	18.94	22.61	8.01	6.45
Inventory Turnover Ratio (X)	14.07	0.00	0.00	0.00	95.25
Dividend Payout Ratio (NP) (%)	0.00	0.00	0.00	0.00	0.00
Dividend Payout Ratio (CP) (%)	0.00	0.00	0.00	0.00	0.00
Earnings Retention Ratio (%)	0.00	0.00	0.00	0.00	0.00
Cash Earnings Retention Ratio (%)	0.00	0.00	0.00	0.00	0.00
Coverage Ratios
Interest Coverage Ratios (%)	-3,323.53	-674.71	-406.21	-220.85	-94.01
Interest Coverage Ratios (Post Tax) (%)	-3,323.53	-674.71	-406.21	-220.85	-94.01
Valuation Ratios
Enterprise Value (Cr.)	2,435.23	2,010.22	872.72	1,343.38	849.81
EV/Net Operating Revenue (X)	365.88	171.92	64.46	113.42	63.05
EV/EBITDA (X)	-15.72	-18.81	-7.43	-11.47	-11.75
MarketCap/Net Operating Revenue (X)	371.55	185.94	78.07	113.85	66.48
Retention Ratios (%)	0.00	0.00	0.00	0.00	0.00
Price/BV (X)	22.48	8.05	2.82	14.02	8.30
Price/Net Operating Revenue	371.56	185.97	78.08	113.85	66.48
Earnings Yield	-0.07	-0.05	-0.11	-0.09	-0.08